MaaT Pharma Announces U.S. FDA Lifts Clinical Hold on Phase 3 Investigational New Drug Application for MaaT013 in Patients with Acute Graft-versus-Host Disease 28 April 2023
Seres Therapeutics and Nestlé Health Science Announce FDA Approval of VOWST™ for Prevention of Recurrence of C. difficile Infection in Adults Following Antibacterial Treatment for Recurrent CDI 27 April 2023
Vedanta Biosciences Announces $106.5 Million Financing to Advance Pipeline of Defined Bacterial Consortia Therapies 26 April 2023
Microbiotica Announces Clinical Trial Collaboration with MSD to Evaluate MB097 in Combination with KEYTRUDA® in a Phase 1b Clinical Trial in Melanoma 13 April 2023
Microbial therapeutics market: Sacco System launches ‘Microbiome’, the suite of active ingredients and services 12 April 2023
